Poiscenter moderators team has a very disappointing announcement to make. Following an unfortunate string of events, the current Rutgers study on POIS, and on the effect of transcutaneous vagal nerve stimulation on POIS, had been stopped early last year, and will not be completed. In early 2016, a complaint had been made by a participant to the Institutional Review Board (IRB) about the study, and the POIS study had been suspended by the IRB for a 10-months investigation. Around late February/early March, the IRB finally issued its report, and the complaint was deemed unfounded, so the research project could have go ahead. However, unexpectedly, Dr Barry Komisaruk has just announced a few days ago that he has decided to terminate his POIS project.
Here some more details about what happened and what is the current situation :
- On August 2015, the Rutgers study began, with a few participants
- Eight months later, around April 2016, the study had been stopped dead in its track by a complaint to the Institutional Review Board (IRB) from one of the early participants. Both the reason for the complaint and the identity of the complainant are confidential, so we do not have this information, and never will. Poiscenter had not been informed at all of the situation, and the IRB asked Dr Komisaruk for secrecy about the fact that a complaint had been made, and about the study being suspended for a ten-months investigation.
- After April 2016, Poiscenter had stopped to receive any interim reports and any information about the study, and the moderators team did not know anything more than you about what was going on. Demo had sent countless communications to NORD and to Dr Komisaruk, but absolutely no information was given to us.
- When we saw that the last interim report, which was due for September 2106, never came, Demo intensified his communications to NORD and to Dr Komisaruk in order to know why this report had never been transmitted to us.
- A few months ago, around November 2016, thanks to Demo's persistence, we finally learned that there had been a complaint months before, and that the study had been totally stopped since then, and that an investigation by the IRB had been going on, and that we had to wait for the IRB conclusions. We were shocked and saddened, and were also very frustrated of not being able to share this information on the forum, because we were asked by NORD and IRB to not make this public, including not posting anything about it on the forum. We suppose that the fact we heard anything at all about this complaint was a kind of leak, as we had been kept totally outside of the process for months.
- Around late February/early March, the IRB report about the complaint had finally been issued, and the complaint had been deemed unfounded. The POIS study had the green light to go on, but probably with some requirements from the IRB about modifying the protocol, to prevent any other problems ( we don't have any other information regarding this). At that point, we were waiting to hear from Dr K, in order to share all of this story, and, as we were hoping, the good news that the study was resuming.
- In a dramatic turn of events, a few weeks after IRB decision had been known, Dr Komisaruk has announced this past week, through a letter to NORD, that he has decided to terminate his POIS study, and will reimburse the received funds to NORD, so that Poiscenter funds will be available for another team, in order to start a new POIS study ( see below for his letter of withdrawal, and the reasons he gives for it )
- NORD is as shocked as we are about Dr Komisaruk's decision, but they will place us on their new list of RFP ( Requests for Proposal) this April, so another research team will be awarded our money by the end of 2017, for a totally new project ( yes, we are back to square one)
Here is Dr Barry Komisaruk's letter to NORD, announcing that he will not go on with his research on POIS:
"Dear demo,
I just sent the following email to Catherine Blansfield of NORD.
Barry"
Dear Catherine,
The IRB investigation into the claim by one of the participants in our POIS project has concluded that his claim of an adverse event related to his participation was “unfounded”.
However, the IRB expressed concern that some of the prospective participants have significant underlying clinical issues. As an academic researcher, I am not prepared to address such clinical issues. Consequently, in order to avoid future such problems, I have decided to terminate the POIS project.
I recognize that the project was “crowd-funded” and am deeply moved and impressed with the seriousness of purpose and commitment of the contributors. I encourage their seeking solution to the debilitating problem of POIS, but regret that I will not be able to perform the proposed research.
Therefore, I have instructed the Rutgers University Grants and Management office to return, as soon as possible, the entire amount of funds that the contributors, through NORD, have provided for my project, which according to that office has been $15,500.00 to date (the originally committed funds totaled $31,000.00). I hope that the contributors will be able to support other research with the returned, plus thus far uncommitted by NORD, funds, to eventually understand and cure POIS.
I thank you, the contributors, and NORD for the wonderful support that you have provided, and wish you the very best of future success.
Sincerely,
Barry
Barry R. Komisaruk, Ph.D.
Distinguished Professor, Psychology
Rutgers Univ Bd of Gov Distinguished Service Professor
Adjunct Professor, Radiology
Rutgers University - Newark
Smith Hall, Rm 327a
101 Warren Street
Newark, NJ 07102
There is nothing we can do about all of this. We have to accept the situation, and understand that Dr. K. made a difficult clinical decision -- one he truly believes is in the best interest of POIS sufferers. Now, we have to look forward for the new research project with a new research team.
We don't know yet if we will be able to get any raw data from what has been done in the few early months of work, like the results from the survey done with forum members. Considering the situation, we should keep our expectations at a low level about recovering anything from the aborted Rutgers project.
We know that all of this sounds unreal, and needless to say that no such scenario ever happened before in a study founded through NORD. Our administrators, Demo, Daveman and Stef, are speechless about all this, and we know that this announcement will cause a lot of emotional reactions. There is no easy way to share this, and we are still digesting these recent events ourselves.
The positive side is that we get a fresh, new start, and no money is lost in the process. We hope that the new project will run smoothly and will bring interesting results for the understanding and treatment of POIS. What happened with this research project have shown that it is a very complex undertaking, and although due to highly unusual events this study failed, thanks to NORD, we are still in a position to complete a viable study properly. It confirms the importance of having a professional medical entity assisting with the analysis of program applicants and all others aspects of the study, and although it is a slow process, it is necessary to assure a complete and viable study.
Also, we have learned some lessons which will help in the filtering of future participants. We are sure NORD will be very careful when reviewing the process which will allow participants in the new study to come.
We will readily share any new information as it becomes available, now that the “secrecy” problem is over.
Sincerely,
Quantum,
on behalf of the whole Poiscenter moderators team.